To study the efficacy of erandadi choorna in the management of renal calculi

A CLINICAL STUDY TO EVALUATE THE EFFECT OF ERANDADI CHURNA IN THE MANAGMENT OF MUTRASHMARI

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/06/025937

Enrollment

Registered

2020-06-17

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N22- Calculus of urinary tract in diseases classified elsewhere Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: Erandadi churna: Erandadi churna (3-5gm) will be given orally in mutrashmari for 30 days Control Intervention1: nil: nil

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients with size of the calculi 8mm or less than 8mm. 2.Patients with calculi any where in Kidney, Ureter, Bladder.

Exclusion criteria

Exclusion criteria: 1.Patients with systemic pathology like Uncontrolled Diabetes Mellitus and Hypertension. 2. Patients have gross Hydronephrosis.etc

Design outcomes

Primary

Measure	Time frame
With the help of radiological investigation renal calculi will be assessed after 30days.Timepoint: With the help of radiological investigation renal calculi will be assessed after 30days.	—

Secondary

Measure	Time frame
nilTimepoint: nil	—

Countries

India

Contacts

Public ContactDr Rajiv Pal

Parul Institute of Ayurved

vivekanandkullolli@gmail.com9945079276

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026